nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—GUCY1A3—renal system—colon cancer	0.00199	0.117	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—renal system—colon cancer	0.00197	0.116	CbGeAlD
Isosorbide Mononitrate—Hypertension—Vincristine—colon cancer	0.00189	0.00193	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Fluorouracil—colon cancer	0.00189	0.00192	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Irinotecan—colon cancer	0.00188	0.00191	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Vincristine—colon cancer	0.00187	0.0019	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Capecitabine—colon cancer	0.00187	0.0019	CcSEcCtD
Isosorbide Mononitrate—Cough—Irinotecan—colon cancer	0.00186	0.0019	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Capecitabine—colon cancer	0.00186	0.00189	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Irinotecan—colon cancer	0.00184	0.00188	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Capecitabine—colon cancer	0.00184	0.00187	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Fluorouracil—colon cancer	0.00183	0.00186	CcSEcCtD
Isosorbide Mononitrate—Acute coronary syndrome—Capecitabine—colon cancer	0.0018	0.00183	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Methotrexate—colon cancer	0.0018	0.00183	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Irinotecan—colon cancer	0.0018	0.00183	CcSEcCtD
Isosorbide Mononitrate—Myocardial infarction—Capecitabine—colon cancer	0.00179	0.00182	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Capecitabine—colon cancer	0.00179	0.00182	CcSEcCtD
Isosorbide Mononitrate—Oedema—Vincristine—colon cancer	0.00179	0.00182	CcSEcCtD
Isosorbide Mononitrate—Infection—Vincristine—colon cancer	0.00178	0.00181	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Capecitabine—colon cancer	0.00178	0.00181	CcSEcCtD
Isosorbide Mononitrate—Urinary tract infection—Capecitabine—colon cancer	0.00178	0.00181	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Methotrexate—colon cancer	0.00177	0.0018	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Irinotecan—colon cancer	0.00176	0.00179	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Vincristine—colon cancer	0.00175	0.00178	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Vincristine—colon cancer	0.00175	0.00178	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Capecitabine—colon cancer	0.00174	0.00177	CcSEcCtD
Isosorbide Mononitrate—Oedema—Irinotecan—colon cancer	0.00174	0.00177	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Fluorouracil—colon cancer	0.00174	0.00177	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Fluorouracil—colon cancer	0.00174	0.00177	CcSEcCtD
Isosorbide Mononitrate—Infection—Irinotecan—colon cancer	0.00173	0.00176	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Vincristine—colon cancer	0.00173	0.00176	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Capecitabine—colon cancer	0.00172	0.00175	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Fluorouracil—colon cancer	0.00172	0.00175	CcSEcCtD
Isosorbide Mononitrate—Shock—Irinotecan—colon cancer	0.00171	0.00174	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Irinotecan—colon cancer	0.00171	0.00174	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Irinotecan—colon cancer	0.00171	0.00174	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Irinotecan—colon cancer	0.00168	0.00171	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Fluorouracil—colon cancer	0.00168	0.00171	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Methotrexate—colon cancer	0.00167	0.0017	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Vincristine—colon cancer	0.00167	0.0017	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Capecitabine—colon cancer	0.00167	0.0017	CcSEcCtD
Isosorbide Mononitrate—Oedema—Fluorouracil—colon cancer	0.00167	0.0017	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Irinotecan—colon cancer	0.00166	0.00169	CcSEcCtD
Isosorbide Mononitrate—Infection—Fluorouracil—colon cancer	0.00166	0.00169	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Capecitabine—colon cancer	0.00165	0.00168	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Capecitabine—colon cancer	0.00165	0.00167	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Capecitabine—colon cancer	0.00164	0.00167	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Fluorouracil—colon cancer	0.00164	0.00166	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Fluorouracil—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Capecitabine—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Vincristine—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Capecitabine—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Fluorouracil—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Irinotecan—colon cancer	0.00163	0.00166	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Capecitabine—colon cancer	0.00162	0.00165	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Vincristine—colon cancer	0.00162	0.00165	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Capecitabine—colon cancer	0.00162	0.00164	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Capecitabine—colon cancer	0.00161	0.00164	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Vincristine—colon cancer	0.00161	0.00163	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Fluorouracil—colon cancer	0.00159	0.00162	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Capecitabine—colon cancer	0.00158	0.00161	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Irinotecan—colon cancer	0.00158	0.0016	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Irinotecan—colon cancer	0.00156	0.00159	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Fluorouracil—colon cancer	0.00156	0.00159	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Vincristine—colon cancer	0.00156	0.00158	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Irinotecan—colon cancer	0.00155	0.00158	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Irinotecan—colon cancer	0.00155	0.00158	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Vincristine—colon cancer	0.00154	0.00157	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Vincristine—colon cancer	0.00154	0.00157	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Irinotecan—colon cancer	0.00153	0.00156	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Capecitabine—colon cancer	0.00153	0.00156	CcSEcCtD
Isosorbide Mononitrate—Pain—Vincristine—colon cancer	0.00153	0.00156	CcSEcCtD
Isosorbide Mononitrate—Constipation—Vincristine—colon cancer	0.00153	0.00156	CcSEcCtD
Isosorbide Mononitrate—Asthma—Methotrexate—colon cancer	0.00153	0.00155	CcSEcCtD
Isosorbide Mononitrate—Flushing—Capecitabine—colon cancer	0.00152	0.00155	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Capecitabine—colon cancer	0.00152	0.00155	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00152	0.00155	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Irinotecan—colon cancer	0.00151	0.00154	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Fluorouracil—colon cancer	0.00151	0.00154	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Irinotecan—colon cancer	0.0015	0.00153	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Irinotecan—colon cancer	0.0015	0.00153	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—bone marrow—colon cancer	0.0015	0.0886	CbGeAlD
Isosorbide Mononitrate—Paraesthesia—Fluorouracil—colon cancer	0.0015	0.00152	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—bone marrow—colon cancer	0.00149	0.088	CbGeAlD
Isosorbide Mononitrate—Constipation—Irinotecan—colon cancer	0.00149	0.00152	CcSEcCtD
Isosorbide Mononitrate—Pain—Irinotecan—colon cancer	0.00149	0.00152	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Fluorouracil—colon cancer	0.00149	0.00151	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Fluorouracil—colon cancer	0.00148	0.00151	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—lymph node—colon cancer	0.00148	0.0872	CbGeAlD
Isosorbide Mononitrate—Chills—Capecitabine—colon cancer	0.00147	0.0015	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Fluorouracil—colon cancer	0.00147	0.00149	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Capecitabine—colon cancer	0.00147	0.00149	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Vincristine—colon cancer	0.00146	0.00149	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Fluorouracil—colon cancer	0.00145	0.00148	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00144	0.00147	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—vagina—colon cancer	0.00144	0.0849	CbGeAlD
Isosorbide Mononitrate—Mental disorder—Capecitabine—colon cancer	0.00144	0.00146	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Irinotecan—colon cancer	0.00144	0.00146	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Capecitabine—colon cancer	0.00143	0.00145	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—vagina—colon cancer	0.00143	0.0843	CbGeAlD
Isosorbide Mononitrate—Dysuria—Methotrexate—colon cancer	0.00143	0.00145	CcSEcCtD
Isosorbide Mononitrate—Pain—Fluorouracil—colon cancer	0.00143	0.00145	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Irinotecan—colon cancer	0.00142	0.00145	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Methotrexate—colon cancer	0.00142	0.00144	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Vincristine—colon cancer	0.00141	0.00144	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Vincristine—colon cancer	0.00141	0.00144	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Capecitabine—colon cancer	0.00141	0.00143	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Methotrexate—colon cancer	0.00141	0.00143	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Isosorbide Mononitrate—Back pain—Capecitabine—colon cancer	0.00138	0.00141	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Irinotecan—colon cancer	0.00138	0.0014	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Irinotecan—colon cancer	0.00138	0.0014	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Fluorouracil—colon cancer	0.00138	0.0014	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Capecitabine—colon cancer	0.00137	0.0014	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Methotrexate—colon cancer	0.00137	0.00139	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Capecitabine—colon cancer	0.00135	0.00137	CcSEcCtD
Isosorbide Mononitrate—Tremor—Capecitabine—colon cancer	0.00134	0.00136	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Capecitabine—colon cancer	0.00133	0.00135	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Methotrexate—colon cancer	0.00132	0.00135	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Capecitabine—colon cancer	0.00132	0.00134	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Fluorouracil—colon cancer	0.00132	0.00134	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Vincristine—colon cancer	0.00132	0.00134	CcSEcCtD
Isosorbide Mononitrate—Sweating—Methotrexate—colon cancer	0.0013	0.00133	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Isosorbide Mononitrate—Malaise—Capecitabine—colon cancer	0.00129	0.00131	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Methotrexate—colon cancer	0.00128	0.00131	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Capecitabine—colon cancer	0.00128	0.00131	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Irinotecan—colon cancer	0.00128	0.00131	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Vincristine—colon cancer	0.00128	0.00131	CcSEcCtD
Isosorbide Mononitrate—Syncope—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Capecitabine—colon cancer	0.00126	0.00128	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Capecitabine—colon cancer	0.00126	0.00128	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Irinotecan—colon cancer	0.00125	0.00127	CcSEcCtD
Isosorbide Mononitrate—Cough—Capecitabine—colon cancer	0.00125	0.00127	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Capecitabine—colon cancer	0.00123	0.00125	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Fluorouracil—colon cancer	0.00123	0.00125	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Methotrexate—colon cancer	0.00123	0.00125	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Vincristine—colon cancer	0.00122	0.00125	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Methotrexate—colon cancer	0.00122	0.00124	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—liver—colon cancer	0.00121	0.0716	CbGeAlD
Isosorbide Mononitrate—Pharyngitis—Methotrexate—colon cancer	0.00121	0.00123	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Capecitabine—colon cancer	0.00121	0.00123	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Methotrexate—colon cancer	0.00121	0.00123	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—liver—colon cancer	0.00121	0.0711	CbGeAlD
Isosorbide Mononitrate—Discomfort—Capecitabine—colon cancer	0.0012	0.00122	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Methotrexate—colon cancer	0.0012	0.00122	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Irinotecan—colon cancer	0.00119	0.00121	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Capecitabine—colon cancer	0.00119	0.00121	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Vincristine—colon cancer	0.00118	0.0012	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Fluorouracil—colon cancer	0.00118	0.0012	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Methotrexate—colon cancer	0.00118	0.0012	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Capecitabine—colon cancer	0.00118	0.0012	CcSEcCtD
Isosorbide Mononitrate—Oedema—Capecitabine—colon cancer	0.00117	0.00119	CcSEcCtD
Isosorbide Mononitrate—Infection—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Irinotecan—colon cancer	0.00115	0.00117	CcSEcCtD
Isosorbide Mononitrate—Shock—Capecitabine—colon cancer	0.00115	0.00117	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Capecitabine—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Fluorouracil—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Capecitabine—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Methotrexate—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Capecitabine—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Vincristine—colon cancer	0.00114	0.00116	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Methotrexate—colon cancer	0.00113	0.00115	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Capecitabine—colon cancer	0.00113	0.00115	CcSEcCtD
Isosorbide Mononitrate—Rash—Vincristine—colon cancer	0.00113	0.00115	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Capecitabine—colon cancer	0.00113	0.00115	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Vincristine—colon cancer	0.00113	0.00115	CcSEcCtD
Isosorbide Mononitrate—Headache—Vincristine—colon cancer	0.00112	0.00114	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Capecitabine—colon cancer	0.00111	0.00113	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Irinotecan—colon cancer	0.00111	0.00113	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Fluorouracil—colon cancer	0.0011	0.00112	CcSEcCtD
Isosorbide Mononitrate—Rash—Irinotecan—colon cancer	0.0011	0.00112	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Irinotecan—colon cancer	0.0011	0.00112	CcSEcCtD
Isosorbide Mononitrate—Chills—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Isosorbide Mononitrate—Headache—Irinotecan—colon cancer	0.00109	0.00111	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Capecitabine—colon cancer	0.00109	0.00111	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Methotrexate—colon cancer	0.00107	0.00109	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Methotrexate—colon cancer	0.00106	0.00108	CcSEcCtD
Isosorbide Mononitrate—Nausea—Vincristine—colon cancer	0.00106	0.00108	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Fluorouracil—colon cancer	0.00106	0.00108	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Capecitabine—colon cancer	0.00105	0.00107	CcSEcCtD
Isosorbide Mononitrate—Rash—Fluorouracil—colon cancer	0.00105	0.00107	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Fluorouracil—colon cancer	0.00105	0.00107	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Capecitabine—colon cancer	0.00105	0.00107	CcSEcCtD
Isosorbide Mononitrate—Headache—Fluorouracil—colon cancer	0.00105	0.00106	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Isosorbide Mononitrate—Nausea—Irinotecan—colon cancer	0.00103	0.00105	CcSEcCtD
Isosorbide Mononitrate—Back pain—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Capecitabine—colon cancer	0.00103	0.00104	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Capecitabine—colon cancer	0.00101	0.00103	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Methotrexate—colon cancer	0.001	0.00102	CcSEcCtD
Isosorbide Mononitrate—Pain—Capecitabine—colon cancer	0.000997	0.00101	CcSEcCtD
Isosorbide Mononitrate—Constipation—Capecitabine—colon cancer	0.000997	0.00101	CcSEcCtD
Isosorbide Mononitrate—Nausea—Fluorouracil—colon cancer	0.000991	0.00101	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Methotrexate—colon cancer	0.000987	0.001	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Methotrexate—colon cancer	0.000983	0.001	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Capecitabine—colon cancer	0.000961	0.000978	CcSEcCtD
Isosorbide Mononitrate—Malaise—Methotrexate—colon cancer	0.000959	0.000976	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Methotrexate—colon cancer	0.000956	0.000972	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Capecitabine—colon cancer	0.000954	0.00097	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Methotrexate—colon cancer	0.000952	0.000969	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—lymph node—colon cancer	0.000931	0.0549	CbGeAlD
Isosorbide Mononitrate—Cough—Methotrexate—colon cancer	0.000928	0.000944	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—lymph node—colon cancer	0.000924	0.0545	CbGeAlD
Isosorbide Mononitrate—Body temperature increased—Capecitabine—colon cancer	0.000922	0.000938	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Capecitabine—colon cancer	0.000922	0.000938	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Methotrexate—colon cancer	0.000906	0.000921	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Methotrexate—colon cancer	0.000906	0.000921	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Methotrexate—colon cancer	0.000906	0.000921	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Methotrexate—colon cancer	0.000895	0.00091	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Methotrexate—colon cancer	0.000875	0.00089	CcSEcCtD
Isosorbide Mononitrate—Infection—Methotrexate—colon cancer	0.000862	0.000877	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Capecitabine—colon cancer	0.000859	0.000874	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Methotrexate—colon cancer	0.000851	0.000866	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Methotrexate—colon cancer	0.00085	0.000865	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Methotrexate—colon cancer	0.000843	0.000858	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Methotrexate—colon cancer	0.000839	0.000854	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Capecitabine—colon cancer	0.000837	0.000851	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Methotrexate—colon cancer	0.000828	0.000842	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Capecitabine—colon cancer	0.000825	0.000839	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Methotrexate—colon cancer	0.000811	0.000825	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Capecitabine—colon cancer	0.000798	0.000812	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000791	0.000805	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Methotrexate—colon cancer	0.000785	0.000799	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Methotrexate—colon cancer	0.00078	0.000793	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Methotrexate—colon cancer	0.000774	0.000787	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Methotrexate—colon cancer	0.000772	0.000785	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Capecitabine—colon cancer	0.000771	0.000784	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Methotrexate—colon cancer	0.000764	0.000777	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Methotrexate—colon cancer	0.000755	0.000768	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000749	0.000762	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Methotrexate—colon cancer	0.000748	0.000761	CcSEcCtD
Isosorbide Mononitrate—Pain—Methotrexate—colon cancer	0.000742	0.000755	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Capecitabine—colon cancer	0.000741	0.000754	CcSEcCtD
Isosorbide Mononitrate—Rash—Capecitabine—colon cancer	0.000735	0.000748	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Capecitabine—colon cancer	0.000735	0.000747	CcSEcCtD
Isosorbide Mononitrate—Headache—Capecitabine—colon cancer	0.000731	0.000743	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Methotrexate—colon cancer	0.000715	0.000728	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Methotrexate—colon cancer	0.00071	0.000722	CcSEcCtD
Isosorbide Mononitrate—Nausea—Capecitabine—colon cancer	0.000693	0.000705	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Methotrexate—colon cancer	0.000686	0.000698	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Methotrexate—colon cancer	0.000686	0.000698	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Methotrexate—colon cancer	0.00064	0.000651	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Methotrexate—colon cancer	0.000623	0.000634	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Methotrexate—colon cancer	0.000614	0.000625	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Methotrexate—colon cancer	0.000594	0.000604	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Methotrexate—colon cancer	0.000574	0.000584	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—renal system—colon cancer	0.000567	0.0335	CbGeAlD
Isosorbide Mononitrate—Vomiting—Methotrexate—colon cancer	0.000552	0.000561	CcSEcCtD
Isosorbide Mononitrate—Rash—Methotrexate—colon cancer	0.000547	0.000557	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Methotrexate—colon cancer	0.000547	0.000556	CcSEcCtD
Isosorbide Mononitrate—Headache—Methotrexate—colon cancer	0.000544	0.000553	CcSEcCtD
Isosorbide Mononitrate—Nausea—Methotrexate—colon cancer	0.000516	0.000525	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—digestive system—colon cancer	0.000465	0.0275	CbGeAlD
Isosorbide Mononitrate—CYP3A4—liver—colon cancer	0.000347	0.0205	CbGeAlD
